Neurocrine(IT:1NBIX)
€154.95+4.75 (+3.16%)
IT:1NBIX
Neurocrine Revenue
€154.95
At close:+4.75 (+3.16%)
Neurocrine (1NBIX) Revenue
0 Followers
Neurocrine Revenue
Neurocrine had a revenue of 1.12B in the quarter ending Sep 30, 2026, with 17.07%. This bring the company's revenue in the last twelve months to 3.70B, Increased 9.72%. In the fiscal year ending Dec 31, 2025, Neurocrine had annual revenue of 2.86B with 21.45% growth.
- Revenue (ttm)
- 3.70B
- Revenue Growth
- 31.81%
- P/S Ratio
- 5.39
- Revenue/Employee
- EUR 1,144,200
- Employees
- 2,500
- Market Cap
- EUR 15.43B
Revenue Chart
Neurocrine Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.86B | 505.20M | 21.45% |
| Dec 31, 2024 | 2.36B | 468.20M | 24.81% |
| Dec 31, 2023 | 1.89B | 398.40M | 26.76% |
| Dec 31, 2022 | 1.49B | 355.20M | 31.34% |
| Dec 31, 2021 | 1.13B | 87.60M | 8.38% |
| Dec 31, 2020 | 1.05B | 257.80M | 32.71% |
| Dec 31, 2019 | 788.10M | 336.90M | 74.67% |
| Dec 31, 2018 | 451.20M | 289.57M | 179.16% |
| Dec 31, 2017 | 161.63M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.